FDA OKs Amneal’s generic Revatio and Amicar; shares up 2% after hours

The FDA approves Amneal Pharmaceuticals’ (NYSE:AMRX) generic versions of Pfizer’s (NYSE:PFE) Revatio (sildenafil citrate) Oral Suspension 10 mg/mL and Clover Pharms’ Amicar (aminocaproic acid) Tablets USP, 500 mg. Commercialization will begin immediately.

Per IQVIA, the U.S. market for the former is ~$180M and ~$23M for the latter.

Shares up 2% after hours.

https://seekingalpha.com/news/3523178-fda-oks-amneals-generic-revatio-amicar-shares-2-percent-hours